New malaria vaccine offers better protection

Sanaria is grabbing headlines with its approach to fighting malaria. Researchers for the company have developed a process to create weakened parasites that create an immune response sufficient to protect 90 percent of patients for a 10-month period. The company's founder, Steven Hoffman, says that the vaccine could be a huge life saver in Africa. Malaria kills about two million people each year, and most of the victims are children.

- read the report from AHN

Related Articles:
Herbal drug used to model new malaria drug. Report
Genome map completed on malaria parasite. Report
WHO: Infectious disease a growing threat. Report